Diagnosing and Preventing Osteoporosis in People With Asthma
People with asthma who must rely on corticosteroids to manage their asthma are at significant risk for bone loss and may benefit from a bone density test, which is the only accurate way to measure current bone mass, diagnose osteoporosis, and predict future fracture risk. This information can help determine if medication is needed to prevent or treat bone loss. Since corticosteroids may increase bone resorption, blood or urine biochemical marker tests can be used to determine if bone is being broken down rapidly.
Several medications are available for the prevention and/or treatment of osteoporosis. These medications can help prevent bone loss and reduce the risk of fracture. People with asthma, particularly those taking corticosteroids, are encouraged to ask their healthcare providers whether they might be a candidate for an osteoporosis medication.